全球組合藥物和醫療設備市場

Drug Device Combination Products

出版日期: 2024年09月01日 | 出版商:

Global Industry Analysts, Inc. | 英文 196 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

2030年全球藥品-醫療設備組合產品市場將達1,587億美元

預計2023年全球組合藥物和醫療設備器材市場規模為1,148億美元，預計2030年將達到1,587億美元，2023-2030年分析期間複合年成長率為4.7%。經皮吸收貼片是本報告分析的細分市場之一，預計複合年成長率為 4.5%，到分析期結束時將達到 534 億美元。在分析期間，吸入器細分市場的複合年成長率預計為 5.8%。

美國市場預估306億美元，中國預期複合年成長率8.3%

預計 2023 年美國藥品/醫療設備組合產品市場規模將達到 306 億美元。中國作為世界第二大經濟體，預計2030年市場規模將達362億美元，2023-2030年分析期間複合年成長率為8.3%。其他值得注意的區域市場包括日本和加拿大，在分析期間預計複合年成長率分別為 1.8% 和 4.9%。在歐洲，德國的複合年成長率預計為 2.1%。

全球藥物/醫療設備組合產品市場 - 主要趨勢與促進因素總結

什麼是藥物/醫療設備組合產品？

組合藥物和醫療設備產品是創新的治療解決方案，將藥物、器材（有時還包括生技藥品）結合，以提高各種醫療狀況治療的有效性、安全性和便利性。這些產品在醫療保健產業中變得越來越重要，因為它們透過協同效應、標靶化藥物傳遞、控制釋放和減少副作用來改善治療結果。常見的例子包括藥物釋放型支架、預填充式注射器、吸入器、經皮吸收貼片和帶有藥物塗層的植入裝置。藥物和設備整合在慢性病管理、腫瘤學和心血管治療中特別有價值，其中精確度、控制和患者依從性至關重要。隨著對個人化和有效治療方法的需求不斷增加，組合藥物和醫療設備產品已成為現代醫療保健的重要組成部分。

技術進步如何推動製藥和醫療設備組合產品市場？

技術進步極大地推動了製藥和醫療設備組合產品市場的成長和開拓。微針貼片、智慧吸入器和生物可吸收支架等藥物傳遞系統的創新正在提高患者的依從性和治療效果。數位健康技術（包括感測器和無線連接）的引入，可以即時監控患者的依從性和藥物輸送，為醫療保健提供者提供寶貴的資料來最佳化治療計劃。此外，生物相容性聚合物和水凝膠等新材料的開發正在提高植入式設備的安全性和有效性，並降低副作用的風險。此外，使用3D列印技術製造組合產品可實現更大程度的客製化和精確度，從而滿足個別患者的特定需求。這些技術進步透過提供滿足未滿足需求的創新解決方案正在改變市場格局。

監管途徑和市場動態如何影響藥物醫療設備組合產品？

藥品/醫療設備組合產品的監管環境很複雜，這些產品必須同時符合藥品和醫療設備的監管標準。 FDA 和 EMA 等監管機構正在製定具體指南，以簡化組合產品的核准流程，加快上市時間，同時確保安全性和有效性。這樣的法律規範透過為組合藥物的開發和商業化提供明確的途徑來促進創新。慢性病盛行率上升、人口老化以及對微創治療的需求等市場動態進一步推動了藥物醫療設備組合產品的採用。對以患者為中心的護理的日益關注以及對具有成本效益的醫療保健解決方案的需求也推動了這些產品的使用，因為它們可以改善治療結果並縮短住院時間。

推動藥品和醫療設備組合產品市場成長的因素有哪些？

藥品和醫療設備組合產品市場的成長受到技術進步、有利的法規環境和慢性病盛行率上升等多種因素的推動。一個關鍵的促進因素是對微創治療的需求不斷成長，以提高患者的依從性和治療結果。數位醫療技術和智慧藥物傳輸系統的日益普及也使得組合產品更加有效和方便，對醫療保健提供者和患者都更具吸引力。此外，不斷擴大的醫療基礎設施以及新興市場對個人化醫療日益成長的興趣正在推動這些產品的開發和採用。製藥公司、醫療設備製造商和研究機構之間的策略聯盟正在進一步推動創新和市場成長。這些因素，加上材料科學和藥物製劑技術的不斷進步，正在推動全球組合藥物和醫療設備產品市場的發展。

受訪企業範例（共46家）

Abbott Laboratories
Alcon, a Novartis Company
Allergan PLC
Arrow International, Inc.
Bausch & Lomb, Inc.
Boston Scientific Corporation
CR Bard, Inc.
CareFusion Corporation
Ethicon US LLC
Medline Industries, Inc.
Medtronic PLC
Mylan NV
Stryker Corporation
Terumo Corporation
WL Gore & Associates, Inc.

The global market for Drug Device Combination Products estimated at US$114.8 Billion in the year 2023, is expected to reach US$158.7 Billion by 2030, growing at a CAGR of 4.7% over the analysis period 2023-2030. Transdermal Patches, one of the segments analyzed in the report, is expected to record a 4.5% CAGR and reach US$53.4 Billion by the end of the analysis period. Growth in the Inhalers segment is estimated at 5.8% CAGR over the analysis period.

The U.S. Market is Estimated at US$30.6 Billion While China is Forecast to Grow at 8.3% CAGR

The Drug Device Combination Products market in the U.S. is estimated at US$30.6 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$36.2 Billion by the year 2030 trailing a CAGR of 8.3% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.8% and 4.9% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.1% CAGR.

Global Drug Device Combination Products Market - Key Trends & Drivers Summarized

What Are Drug Device Combination Products And Why Are They Important?

Drug device combination products are innovative therapeutic solutions that combine drugs, devices, and sometimes biologics to improve the efficacy, safety, and convenience of treatment for various medical conditions. These products are increasingly gaining importance in the healthcare industry as they offer enhanced treatment outcomes through synergistic effects, providing targeted drug delivery, controlled release, and reduced side effects. Common examples include drug-eluting stents, prefilled syringes, inhalers, transdermal patches, and implantable devices with drug coatings. The integration of drugs and devices is particularly valuable in chronic disease management, oncology, and cardiovascular treatments, where precision, control, and patient adherence are critical. As the demand for personalized and effective treatment options grows, drug device combination products are becoming an essential component of modern healthcare.

How Are Technological Advancements Driving The Drug Device Combination Products Market?

Technological advancements are significantly driving the growth and development of the drug device combination products market. Innovations in drug delivery systems, such as microneedle patches, smart inhalers, and bioresorbable stents, are enhancing patient compliance and therapeutic effectiveness. The incorporation of digital health technologies, including sensors and wireless connectivity, is enabling real-time monitoring of patient adherence and drug delivery, providing valuable data to healthcare providers for optimizing treatment plans. Additionally, the development of novel materials, such as biocompatible polymers and hydrogels, is improving the safety and efficacy of implantable devices, reducing the risk of adverse reactions. The use of 3D printing technology in manufacturing combination products is also allowing for greater customization and precision, catering to the specific needs of individual patients. These technological advancements are transforming the market landscape by offering innovative solutions that address unmet clinical needs.

How Are Regulatory Pathways And Market Dynamics Impacting Drug Device Combination Products?

The regulatory landscape for drug device combination products is complex, as these products must meet the standards of both drug and device regulations. Regulatory bodies such as the FDA and EMA are increasingly developing specific guidelines to streamline the approval process for combination products, ensuring safety and efficacy while reducing time to market. These regulatory frameworks are encouraging innovation by providing clearer pathways for the development and commercialization of combination products. Market dynamics, such as the rising prevalence of chronic diseases, the aging population, and the demand for minimally invasive treatments, are further driving the adoption of drug device combination products. The increasing focus on patient-centric care and the need for cost-effective healthcare solutions are also promoting the use of these products, as they offer improved treatment outcomes and reduced hospital stays.

What Factors Are Driving The Growth Of The Drug Device Combination Products Market?

The growth in the drug device combination products market is driven by several factors, including technological advancements, favorable regulatory environments, and the rising prevalence of chronic diseases. A key driver is the increasing demand for minimally invasive treatments that offer better patient compliance and outcomes. The growing adoption of digital health technologies and smart drug delivery systems is also enhancing the effectiveness and convenience of combination products, making them more attractive to both healthcare providers and patients. Additionally, the expansion of healthcare infrastructure in emerging markets and the increasing focus on personalized medicine are supporting the development and adoption of these products. Strategic collaborations between pharmaceutical companies, medical device manufacturers, and research institutions are further propelling innovation and market growth. These factors, coupled with the continuous advancement of materials science and drug formulation technologies, are driving the global market for drug device combination products forward.

Select Competitors (Total 46 Featured) -

Abbott Laboratories
Alcon, a Novartis Company
Allergan PLC
Arrow International, Inc.
Bausch & Lomb, Inc.
Boston Scientific Corporation
C.R. Bard, Inc.
CareFusion Corporation
Ethicon US LLC
Medline Industries, Inc.
Medtronic PLC
Mylan NV
Stryker Corporation
Terumo Corporation
W. L. Gore & Associates, Inc.

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
- Influencer Market Insights
- World Market Trajectories
- Impact of Covid-19 and a Looming Global Recession
- Drug Device Combination Products - Global Key Competitors Percentage Market Share in 2024 (E)
- Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
- Rising Demand for Minimally Invasive Treatment Solutions
- Increasing Adoption of Drug-Eluting Stents and Implantable Devices
- Technological Advancements in Drug Delivery Mechanisms for Enhanced Efficacy
- Growing Focus on Patient-Centric and Personalized Healthcare Solutions
- Expansion of Applications for Combination Products in Chronic Disease Management
- Impact of Regulatory Approvals and Fast-Track Designations on Market Growth
- Increasing Collaborations Between Pharmaceutical and Medical Device Companies
- Development of Smart Drug Device Combinations with Digital Health Integration
- Rising Demand for Biodegradable and Implantable Drug Delivery Systems
- Impact of Aging Population and Growing Burden of Chronic Diseases
- Growing Investments in R&D for Novel Combination Products
- Emerging Opportunities in Emerging Markets for Drug Device Combinations
4. GLOBAL MARKET PERSPECTIVE
- TABLE 1: World Drug Device Combination Products Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
- TABLE 2: World Recent Past, Current & Future Analysis for Drug Device Combination Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
- TABLE 3: World Historic Review for Drug Device Combination Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 4: World 16-Year Perspective for Drug Device Combination Products by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
- TABLE 5: World Recent Past, Current & Future Analysis for Transdermal Patches by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
- TABLE 6: World Historic Review for Transdermal Patches by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 7: World 16-Year Perspective for Transdermal Patches by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
- TABLE 8: World Recent Past, Current & Future Analysis for Inhalers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
- TABLE 9: World Historic Review for Inhalers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 10: World 16-Year Perspective for Inhalers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
- TABLE 11: World Recent Past, Current & Future Analysis for Drug Eluting Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
- TABLE 12: World Historic Review for Drug Eluting Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 13: World 16-Year Perspective for Drug Eluting Stents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
- TABLE 14: World Recent Past, Current & Future Analysis for Prefilled Syringes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
- TABLE 15: World Historic Review for Prefilled Syringes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 16: World 16-Year Perspective for Prefilled Syringes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
- TABLE 17: World Recent Past, Current & Future Analysis for Photodynamic Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
- TABLE 18: World Historic Review for Photodynamic Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 19: World 16-Year Perspective for Photodynamic Therapy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
- TABLE 20: World Recent Past, Current & Future Analysis for Nebulizers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
- TABLE 21: World Historic Review for Nebulizers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 22: World 16-Year Perspective for Nebulizers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
- TABLE 23: World Recent Past, Current & Future Analysis for Antimicrobial Wound Dressings by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
- TABLE 24: World Historic Review for Antimicrobial Wound Dressings by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 25: World 16-Year Perspective for Antimicrobial Wound Dressings by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
- TABLE 26: World Recent Past, Current & Future Analysis for Other Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
- TABLE 27: World Historic Review for Other Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 28: World 16-Year Perspective for Other Products by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
- TABLE 29: World Recent Past, Current & Future Analysis for Hospitals & Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
- TABLE 30: World Historic Review for Hospitals & Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 31: World 16-Year Perspective for Hospitals & Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
- TABLE 32: World Recent Past, Current & Future Analysis for Home Care Setting by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
- TABLE 33: World Historic Review for Home Care Setting by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 34: World 16-Year Perspective for Home Care Setting by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
- TABLE 35: World Recent Past, Current & Future Analysis for Ambulatory Surgery Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
- TABLE 36: World Historic Review for Ambulatory Surgery Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 37: World 16-Year Perspective for Ambulatory Surgery Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
- TABLE 38: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
- TABLE 39: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 40: World 16-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

UNITED STATES
- Drug Device Combination Products Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
- TABLE 41: USA Recent Past, Current & Future Analysis for Drug Device Combination Products by Product - Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 42: USA Historic Review for Drug Device Combination Products by Product - Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 43: USA 16-Year Perspective for Drug Device Combination Products by Product - Percentage Breakdown of Value Sales for Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products for the Years 2014, 2024 & 2030
- TABLE 44: USA Recent Past, Current & Future Analysis for Drug Device Combination Products by End-Use - Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 45: USA Historic Review for Drug Device Combination Products by End-Use - Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 46: USA 16-Year Perspective for Drug Device Combination Products by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2024 & 2030
CANADA
- TABLE 47: Canada Recent Past, Current & Future Analysis for Drug Device Combination Products by Product - Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 48: Canada Historic Review for Drug Device Combination Products by Product - Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 49: Canada 16-Year Perspective for Drug Device Combination Products by Product - Percentage Breakdown of Value Sales for Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products for the Years 2014, 2024 & 2030
- TABLE 50: Canada Recent Past, Current & Future Analysis for Drug Device Combination Products by End-Use - Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 51: Canada Historic Review for Drug Device Combination Products by End-Use - Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 52: Canada 16-Year Perspective for Drug Device Combination Products by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2024 & 2030
JAPAN
- Drug Device Combination Products Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
- TABLE 53: Japan Recent Past, Current & Future Analysis for Drug Device Combination Products by Product - Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 54: Japan Historic Review for Drug Device Combination Products by Product - Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 55: Japan 16-Year Perspective for Drug Device Combination Products by Product - Percentage Breakdown of Value Sales for Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products for the Years 2014, 2024 & 2030
- TABLE 56: Japan Recent Past, Current & Future Analysis for Drug Device Combination Products by End-Use - Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 57: Japan Historic Review for Drug Device Combination Products by End-Use - Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 58: Japan 16-Year Perspective for Drug Device Combination Products by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2024 & 2030
CHINA
- Drug Device Combination Products Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
- TABLE 59: China Recent Past, Current & Future Analysis for Drug Device Combination Products by Product - Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 60: China Historic Review for Drug Device Combination Products by Product - Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 61: China 16-Year Perspective for Drug Device Combination Products by Product - Percentage Breakdown of Value Sales for Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products for the Years 2014, 2024 & 2030
- TABLE 62: China Recent Past, Current & Future Analysis for Drug Device Combination Products by End-Use - Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 63: China Historic Review for Drug Device Combination Products by End-Use - Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 64: China 16-Year Perspective for Drug Device Combination Products by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2024 & 2030
EUROPE
- Drug Device Combination Products Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
- TABLE 65: Europe Recent Past, Current & Future Analysis for Drug Device Combination Products by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
- TABLE 66: Europe Historic Review for Drug Device Combination Products by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 67: Europe 16-Year Perspective for Drug Device Combination Products by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
- TABLE 68: Europe Recent Past, Current & Future Analysis for Drug Device Combination Products by Product - Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 69: Europe Historic Review for Drug Device Combination Products by Product - Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 70: Europe 16-Year Perspective for Drug Device Combination Products by Product - Percentage Breakdown of Value Sales for Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products for the Years 2014, 2024 & 2030
- TABLE 71: Europe Recent Past, Current & Future Analysis for Drug Device Combination Products by End-Use - Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 72: Europe Historic Review for Drug Device Combination Products by End-Use - Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 73: Europe 16-Year Perspective for Drug Device Combination Products by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2024 & 2030
FRANCE
- Drug Device Combination Products Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
- TABLE 74: France Recent Past, Current & Future Analysis for Drug Device Combination Products by Product - Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 75: France Historic Review for Drug Device Combination Products by Product - Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 76: France 16-Year Perspective for Drug Device Combination Products by Product - Percentage Breakdown of Value Sales for Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products for the Years 2014, 2024 & 2030
- TABLE 77: France Recent Past, Current & Future Analysis for Drug Device Combination Products by End-Use - Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 78: France Historic Review for Drug Device Combination Products by End-Use - Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 79: France 16-Year Perspective for Drug Device Combination Products by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2024 & 2030
GERMANY
- Drug Device Combination Products Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
- TABLE 80: Germany Recent Past, Current & Future Analysis for Drug Device Combination Products by Product - Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 81: Germany Historic Review for Drug Device Combination Products by Product - Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 82: Germany 16-Year Perspective for Drug Device Combination Products by Product - Percentage Breakdown of Value Sales for Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products for the Years 2014, 2024 & 2030
- TABLE 83: Germany Recent Past, Current & Future Analysis for Drug Device Combination Products by End-Use - Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 84: Germany Historic Review for Drug Device Combination Products by End-Use - Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 85: Germany 16-Year Perspective for Drug Device Combination Products by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2024 & 2030
ITALY
- TABLE 86: Italy Recent Past, Current & Future Analysis for Drug Device Combination Products by Product - Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 87: Italy Historic Review for Drug Device Combination Products by Product - Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 88: Italy 16-Year Perspective for Drug Device Combination Products by Product - Percentage Breakdown of Value Sales for Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products for the Years 2014, 2024 & 2030
- TABLE 89: Italy Recent Past, Current & Future Analysis for Drug Device Combination Products by End-Use - Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 90: Italy Historic Review for Drug Device Combination Products by End-Use - Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 91: Italy 16-Year Perspective for Drug Device Combination Products by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2024 & 2030
UNITED KINGDOM
- Drug Device Combination Products Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
- TABLE 92: UK Recent Past, Current & Future Analysis for Drug Device Combination Products by Product - Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 93: UK Historic Review for Drug Device Combination Products by Product - Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 94: UK 16-Year Perspective for Drug Device Combination Products by Product - Percentage Breakdown of Value Sales for Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products for the Years 2014, 2024 & 2030
- TABLE 95: UK Recent Past, Current & Future Analysis for Drug Device Combination Products by End-Use - Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 96: UK Historic Review for Drug Device Combination Products by End-Use - Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 97: UK 16-Year Perspective for Drug Device Combination Products by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2024 & 2030
SPAIN
- TABLE 98: Spain Recent Past, Current & Future Analysis for Drug Device Combination Products by Product - Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 99: Spain Historic Review for Drug Device Combination Products by Product - Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 100: Spain 16-Year Perspective for Drug Device Combination Products by Product - Percentage Breakdown of Value Sales for Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products for the Years 2014, 2024 & 2030
- TABLE 101: Spain Recent Past, Current & Future Analysis for Drug Device Combination Products by End-Use - Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 102: Spain Historic Review for Drug Device Combination Products by End-Use - Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 103: Spain 16-Year Perspective for Drug Device Combination Products by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2024 & 2030
RUSSIA
- TABLE 104: Russia Recent Past, Current & Future Analysis for Drug Device Combination Products by Product - Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 105: Russia Historic Review for Drug Device Combination Products by Product - Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 106: Russia 16-Year Perspective for Drug Device Combination Products by Product - Percentage Breakdown of Value Sales for Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products for the Years 2014, 2024 & 2030
- TABLE 107: Russia Recent Past, Current & Future Analysis for Drug Device Combination Products by End-Use - Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 108: Russia Historic Review for Drug Device Combination Products by End-Use - Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 109: Russia 16-Year Perspective for Drug Device Combination Products by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2024 & 2030
REST OF EUROPE
- TABLE 110: Rest of Europe Recent Past, Current & Future Analysis for Drug Device Combination Products by Product - Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 111: Rest of Europe Historic Review for Drug Device Combination Products by Product - Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 112: Rest of Europe 16-Year Perspective for Drug Device Combination Products by Product - Percentage Breakdown of Value Sales for Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products for the Years 2014, 2024 & 2030
- TABLE 113: Rest of Europe Recent Past, Current & Future Analysis for Drug Device Combination Products by End-Use - Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 114: Rest of Europe Historic Review for Drug Device Combination Products by End-Use - Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 115: Rest of Europe 16-Year Perspective for Drug Device Combination Products by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2024 & 2030
ASIA-PACIFIC
- Drug Device Combination Products Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
- TABLE 116: Asia-Pacific Recent Past, Current & Future Analysis for Drug Device Combination Products by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
- TABLE 117: Asia-Pacific Historic Review for Drug Device Combination Products by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 118: Asia-Pacific 16-Year Perspective for Drug Device Combination Products by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
- TABLE 119: Asia-Pacific Recent Past, Current & Future Analysis for Drug Device Combination Products by Product - Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 120: Asia-Pacific Historic Review for Drug Device Combination Products by Product - Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 121: Asia-Pacific 16-Year Perspective for Drug Device Combination Products by Product - Percentage Breakdown of Value Sales for Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products for the Years 2014, 2024 & 2030
- TABLE 122: Asia-Pacific Recent Past, Current & Future Analysis for Drug Device Combination Products by End-Use - Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 123: Asia-Pacific Historic Review for Drug Device Combination Products by End-Use - Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 124: Asia-Pacific 16-Year Perspective for Drug Device Combination Products by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2024 & 2030
AUSTRALIA
- Drug Device Combination Products Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
- TABLE 125: Australia Recent Past, Current & Future Analysis for Drug Device Combination Products by Product - Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 126: Australia Historic Review for Drug Device Combination Products by Product - Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 127: Australia 16-Year Perspective for Drug Device Combination Products by Product - Percentage Breakdown of Value Sales for Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products for the Years 2014, 2024 & 2030
- TABLE 128: Australia Recent Past, Current & Future Analysis for Drug Device Combination Products by End-Use - Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 129: Australia Historic Review for Drug Device Combination Products by End-Use - Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 130: Australia 16-Year Perspective for Drug Device Combination Products by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2024 & 2030
INDIA
- Drug Device Combination Products Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
- TABLE 131: India Recent Past, Current & Future Analysis for Drug Device Combination Products by Product - Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 132: India Historic Review for Drug Device Combination Products by Product - Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 133: India 16-Year Perspective for Drug Device Combination Products by Product - Percentage Breakdown of Value Sales for Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products for the Years 2014, 2024 & 2030
- TABLE 134: India Recent Past, Current & Future Analysis for Drug Device Combination Products by End-Use - Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 135: India Historic Review for Drug Device Combination Products by End-Use - Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 136: India 16-Year Perspective for Drug Device Combination Products by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2024 & 2030
SOUTH KOREA
- TABLE 137: South Korea Recent Past, Current & Future Analysis for Drug Device Combination Products by Product - Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 138: South Korea Historic Review for Drug Device Combination Products by Product - Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 139: South Korea 16-Year Perspective for Drug Device Combination Products by Product - Percentage Breakdown of Value Sales for Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products for the Years 2014, 2024 & 2030
- TABLE 140: South Korea Recent Past, Current & Future Analysis for Drug Device Combination Products by End-Use - Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 141: South Korea Historic Review for Drug Device Combination Products by End-Use - Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 142: South Korea 16-Year Perspective for Drug Device Combination Products by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2024 & 2030
REST OF ASIA-PACIFIC
- TABLE 143: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Drug Device Combination Products by Product - Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 144: Rest of Asia-Pacific Historic Review for Drug Device Combination Products by Product - Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 145: Rest of Asia-Pacific 16-Year Perspective for Drug Device Combination Products by Product - Percentage Breakdown of Value Sales for Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products for the Years 2014, 2024 & 2030
- TABLE 146: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Drug Device Combination Products by End-Use - Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 147: Rest of Asia-Pacific Historic Review for Drug Device Combination Products by End-Use - Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 148: Rest of Asia-Pacific 16-Year Perspective for Drug Device Combination Products by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2024 & 2030
LATIN AMERICA
- Drug Device Combination Products Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
- TABLE 149: Latin America Recent Past, Current & Future Analysis for Drug Device Combination Products by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
- TABLE 150: Latin America Historic Review for Drug Device Combination Products by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 151: Latin America 16-Year Perspective for Drug Device Combination Products by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
- TABLE 152: Latin America Recent Past, Current & Future Analysis for Drug Device Combination Products by Product - Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 153: Latin America Historic Review for Drug Device Combination Products by Product - Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 154: Latin America 16-Year Perspective for Drug Device Combination Products by Product - Percentage Breakdown of Value Sales for Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products for the Years 2014, 2024 & 2030
- TABLE 155: Latin America Recent Past, Current & Future Analysis for Drug Device Combination Products by End-Use - Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 156: Latin America Historic Review for Drug Device Combination Products by End-Use - Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 157: Latin America 16-Year Perspective for Drug Device Combination Products by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2024 & 2030
ARGENTINA
- TABLE 158: Argentina Recent Past, Current & Future Analysis for Drug Device Combination Products by Product - Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 159: Argentina Historic Review for Drug Device Combination Products by Product - Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 160: Argentina 16-Year Perspective for Drug Device Combination Products by Product - Percentage Breakdown of Value Sales for Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products for the Years 2014, 2024 & 2030
- TABLE 161: Argentina Recent Past, Current & Future Analysis for Drug Device Combination Products by End-Use - Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 162: Argentina Historic Review for Drug Device Combination Products by End-Use - Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 163: Argentina 16-Year Perspective for Drug Device Combination Products by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2024 & 2030
BRAZIL
- TABLE 164: Brazil Recent Past, Current & Future Analysis for Drug Device Combination Products by Product - Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 165: Brazil Historic Review for Drug Device Combination Products by Product - Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 166: Brazil 16-Year Perspective for Drug Device Combination Products by Product - Percentage Breakdown of Value Sales for Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products for the Years 2014, 2024 & 2030
- TABLE 167: Brazil Recent Past, Current & Future Analysis for Drug Device Combination Products by End-Use - Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 168: Brazil Historic Review for Drug Device Combination Products by End-Use - Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 169: Brazil 16-Year Perspective for Drug Device Combination Products by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2024 & 2030
MEXICO
- TABLE 170: Mexico Recent Past, Current & Future Analysis for Drug Device Combination Products by Product - Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 171: Mexico Historic Review for Drug Device Combination Products by Product - Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 172: Mexico 16-Year Perspective for Drug Device Combination Products by Product - Percentage Breakdown of Value Sales for Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products for the Years 2014, 2024 & 2030
- TABLE 173: Mexico Recent Past, Current & Future Analysis for Drug Device Combination Products by End-Use - Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 174: Mexico Historic Review for Drug Device Combination Products by End-Use - Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 175: Mexico 16-Year Perspective for Drug Device Combination Products by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2024 & 2030
REST OF LATIN AMERICA
- TABLE 176: Rest of Latin America Recent Past, Current & Future Analysis for Drug Device Combination Products by Product - Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 177: Rest of Latin America Historic Review for Drug Device Combination Products by Product - Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 178: Rest of Latin America 16-Year Perspective for Drug Device Combination Products by Product - Percentage Breakdown of Value Sales for Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products for the Years 2014, 2024 & 2030
- TABLE 179: Rest of Latin America Recent Past, Current & Future Analysis for Drug Device Combination Products by End-Use - Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 180: Rest of Latin America Historic Review for Drug Device Combination Products by End-Use - Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 181: Rest of Latin America 16-Year Perspective for Drug Device Combination Products by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2024 & 2030
MIDDLE EAST
- Drug Device Combination Products Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
- TABLE 182: Middle East Recent Past, Current & Future Analysis for Drug Device Combination Products by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
- TABLE 183: Middle East Historic Review for Drug Device Combination Products by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 184: Middle East 16-Year Perspective for Drug Device Combination Products by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
- TABLE 185: Middle East Recent Past, Current & Future Analysis for Drug Device Combination Products by Product - Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 186: Middle East Historic Review for Drug Device Combination Products by Product - Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 187: Middle East 16-Year Perspective for Drug Device Combination Products by Product - Percentage Breakdown of Value Sales for Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products for the Years 2014, 2024 & 2030
- TABLE 188: Middle East Recent Past, Current & Future Analysis for Drug Device Combination Products by End-Use - Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 189: Middle East Historic Review for Drug Device Combination Products by End-Use - Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 190: Middle East 16-Year Perspective for Drug Device Combination Products by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2024 & 2030
IRAN
- TABLE 191: Iran Recent Past, Current & Future Analysis for Drug Device Combination Products by Product - Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 192: Iran Historic Review for Drug Device Combination Products by Product - Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 193: Iran 16-Year Perspective for Drug Device Combination Products by Product - Percentage Breakdown of Value Sales for Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products for the Years 2014, 2024 & 2030
- TABLE 194: Iran Recent Past, Current & Future Analysis for Drug Device Combination Products by End-Use - Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 195: Iran Historic Review for Drug Device Combination Products by End-Use - Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 196: Iran 16-Year Perspective for Drug Device Combination Products by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2024 & 2030
ISRAEL
- TABLE 197: Israel Recent Past, Current & Future Analysis for Drug Device Combination Products by Product - Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 198: Israel Historic Review for Drug Device Combination Products by Product - Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 199: Israel 16-Year Perspective for Drug Device Combination Products by Product - Percentage Breakdown of Value Sales for Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products for the Years 2014, 2024 & 2030
- TABLE 200: Israel Recent Past, Current & Future Analysis for Drug Device Combination Products by End-Use - Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 201: Israel Historic Review for Drug Device Combination Products by End-Use - Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 202: Israel 16-Year Perspective for Drug Device Combination Products by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2024 & 2030
SAUDI ARABIA
- TABLE 203: Saudi Arabia Recent Past, Current & Future Analysis for Drug Device Combination Products by Product - Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 204: Saudi Arabia Historic Review for Drug Device Combination Products by Product - Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 205: Saudi Arabia 16-Year Perspective for Drug Device Combination Products by Product - Percentage Breakdown of Value Sales for Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products for the Years 2014, 2024 & 2030
- TABLE 206: Saudi Arabia Recent Past, Current & Future Analysis for Drug Device Combination Products by End-Use - Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 207: Saudi Arabia Historic Review for Drug Device Combination Products by End-Use - Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 208: Saudi Arabia 16-Year Perspective for Drug Device Combination Products by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2024 & 2030
UNITED ARAB EMIRATES
- TABLE 209: UAE Recent Past, Current & Future Analysis for Drug Device Combination Products by Product - Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 210: UAE Historic Review for Drug Device Combination Products by Product - Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 211: UAE 16-Year Perspective for Drug Device Combination Products by Product - Percentage Breakdown of Value Sales for Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products for the Years 2014, 2024 & 2030
- TABLE 212: UAE Recent Past, Current & Future Analysis for Drug Device Combination Products by End-Use - Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 213: UAE Historic Review for Drug Device Combination Products by End-Use - Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 214: UAE 16-Year Perspective for Drug Device Combination Products by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2024 & 2030
REST OF MIDDLE EAST
- TABLE 215: Rest of Middle East Recent Past, Current & Future Analysis for Drug Device Combination Products by Product - Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 216: Rest of Middle East Historic Review for Drug Device Combination Products by Product - Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 217: Rest of Middle East 16-Year Perspective for Drug Device Combination Products by Product - Percentage Breakdown of Value Sales for Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products for the Years 2014, 2024 & 2030
- TABLE 218: Rest of Middle East Recent Past, Current & Future Analysis for Drug Device Combination Products by End-Use - Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 219: Rest of Middle East Historic Review for Drug Device Combination Products by End-Use - Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 220: Rest of Middle East 16-Year Perspective for Drug Device Combination Products by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2024 & 2030
AFRICA
- Drug Device Combination Products Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
- TABLE 221: Africa Recent Past, Current & Future Analysis for Drug Device Combination Products by Product - Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 222: Africa Historic Review for Drug Device Combination Products by Product - Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 223: Africa 16-Year Perspective for Drug Device Combination Products by Product - Percentage Breakdown of Value Sales for Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products for the Years 2014, 2024 & 2030
- TABLE 224: Africa Recent Past, Current & Future Analysis for Drug Device Combination Products by End-Use - Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 225: Africa Historic Review for Drug Device Combination Products by End-Use - Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 226: Africa 16-Year Perspective for Drug Device Combination Products by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2024 & 2030